Does RIVAROXABAN Cause Disseminated intravascular coagulation? 100 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 100 reports of Disseminated intravascular coagulation have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.1% of all adverse event reports for RIVAROXABAN.
100
Reports of Disseminated intravascular coagulation with RIVAROXABAN
0.1%
of all RIVAROXABAN reports
56
Deaths
62
Hospitalizations
How Dangerous Is Disseminated intravascular coagulation From RIVAROXABAN?
Of the 100 reports, 56 (56.0%) resulted in death, 62 (62.0%) required hospitalization, and 10 (10.0%) were considered life-threatening.
Is Disseminated intravascular coagulation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 100 reports have been filed with the FAERS database.
What Other Side Effects Does RIVAROXABAN Cause?
Gastrointestinal haemorrhage (20,041)
Haemorrhage (6,571)
Epistaxis (5,629)
Rectal haemorrhage (4,501)
Off label use (4,463)
Haematuria (4,387)
Upper gastrointestinal haemorrhage (4,247)
Cerebrovascular accident (4,111)
Anaemia (3,907)
Acute kidney injury (3,735)
What Other Drugs Cause Disseminated intravascular coagulation?
PREDNISOLONE (362)
METHOTREXATE (347)
DEXAMETHASONE (323)
METHYLPREDNISOLONE (307)
NIVOLUMAB (305)
CYCLOPHOSPHAMIDE (286)
TACROLIMUS (278)
PREDNISONE (277)
VINCRISTINE (245)
OXALIPLATIN (231)
Which RIVAROXABAN Alternatives Have Lower Disseminated intravascular coagulation Risk?
RIVAROXABAN vs RIVASTIGMINE
RIVAROXABAN vs RIVOTRIL
RIVAROXABAN vs RIZATRIPTAN
RIVAROXABAN vs ROACTEMRA
RIVAROXABAN vs ROCURONIUM